Bonafide, type-specific human papillomavirus persistence among HIV-positive pregnant women: predictive value for cytological abnormalities, a longitudinal cohort study
Open Access
- 1 February 2016
- journal article
- research article
- Published by FapUNIFESP (SciELO) in Memórias do Instituto Oswaldo Cruz
- Vol. 111 (2) , 120-127
Abstract
This study investigated the rate of human papillomavirus (HPV) persistence, associated risk factors, and predictors of cytological alteration outcomes in a cohort of human immunodeficiency virus-infected pregnant women over an 18-month period. HPV was typed through L1 gene sequencing in cervical smears collected during gestation and at 12 months after delivery. Outcomes were defined as nonpersistence (clearance of the HPV in the 2nd sample), re-infection (detection of different types of HPV in the 2 samples), and type-specific HPV persistence (the same HPV type found in both samples). An unfavourable cytological outcome was considered when the second exam showed progression to squamous intraepithelial lesion or high squamous intraepithelial lesion. Ninety patients were studied. HPV DNA persistence occurred in 50% of the cases composed of type-specific persistence (30%) or re-infection (20%). A low CD4+T-cell count at entry was a risk factor for type-specific, re-infection, or HPV DNA persistence. The odds ratio (OR) was almost three times higher in the type-specific group when compared with the re-infection group (OR = 2.8; 95% confidence interval: 0.43-22.79). Our findings show that bonafide (type-specific) HPV persistence is a stronger predictor for the development of cytological abnormalities, highlighting the need for HPV typing as opposed to HPV DNA testing in the clinical setting.Keywords
This publication has 34 references indexed in Scilit:
- HPV clearance in postpartum period of HIV-positive and negative women: a prospective follow-up studyBMC Infectious Diseases, 2013
- Human papillomavirus (HPV) types 16, 18, 31, 45 DNA loads and HPV-16 integration in persistent and transient infections in young womenBMC Infectious Diseases, 2010
- HPV - immune response to infection and vaccinationInfectious Agents and Cancer, 2010
- Human immunodeficiency virus and human papilloma virus - why HPV-induced lesions do not spontaneously resolve and why therapeutic vaccination can be successfulJournal of Translational Medicine, 2009
- Human Papillomavirus (HPV) infection in pregnant women and mother-to-child transmission of genital HPV genotypes: a prospective study in SpainBMC Infectious Diseases, 2009
- Common Genetic Variation in TP53 and Risk of Human Papillomavirus Persistence and Progression to CIN3/Cancer RevisitedCancer Epidemiology, Biomarkers & Prevention, 2009
- Cervical Human Papillomavirus Incidence and Persistence in a Cohort of HIV-Negative Women in ZimbabweSexually Transmitted Diseases, 2009
- Papillomaviruses in the causation of human cancers — a brief historical accountVirology, 2009
- Persistent Human Papillomavirus Infection and Cervical Neoplasia: A Systematic Review and Meta-AnalysisAmerican Journal of Epidemiology, 2008
- Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical CancerNew England Journal of Medicine, 2003